Dr. Kantrow has directed the LSUHSC New Orleans fellowship training program in pulmonary
and critical care medicine since 2009, a combined effort of LSUHSC and Ochsner Health.
His areas of clinical interest are critical care medicine, palliative medicine and
neuromuscular pulmonary diseases. He has cared for people living with ALS in multidiscipinary
clinics at LSUHSC and Ochsner since 2011, providing pulmonary, palliative and critical
care expertise. His most recent publications have been population research in tobacco
use, guideline development for treatment of tobacco dependence, and care of critically
ill patients with COVID. For the fellowship training program, he has developed international
exchange programs with colleagues in Vietnam, India and Brazil.
Undergraduate: 1980-1984 - B.A. Yale University New Haven, Connecticut
Medical: 1984-1988 - M.D. LSU School of Medicine New Orleans, Louisiana
Residency: 1988-1991 - Internal Medicine Duke University Medical Center Durham, North Carolina
Fellowship: 1991-1993 - Pulmonary and Critical Care Medicine University of Washington Medical Center Seattle, Washington
Chief Residency: 1983-1994 - Internal Medicine Duke University Medical Center Durham, North Carolina
Fellowship: 1994-1995 - Pulmonary and Critical Care Medicine Duke University Medical Center Durham, North Carolina
Affiliated Hospitals & Clinics
Ochsner Medical Center
LSU Healthcare Network Multispecialty
1. Kantrow SP, Jolley SE, Price-Haywood EG, Wang X, Tseng TS, Arnold D, Brown L, Leonardi C, Scribner
RA, Trapido EJ, Lin HY. Using the Emergency Department to Investigate Smoking in Young
Adults. Ann Epidemiol 2019; 30: 44-49.
2. Nguyen Ho L, Tran Van N, Le Thuong V, Hoang Chan P, Kantrow SP, Duong Duy K, Smith DL. Hilar asymmetry in endobronchial tuberculosis patients: an
often-overlooked clue. Int J Infect Dis. 2019; 80: 80-83.
3. Ghio AJ, Soukup JM, Stonehuerner J, Tong H, Richards J, Gilmour MI, Madden MC,
Shen Z, Kantrow SP. Quartz Disrupts Iron Homeostasis in Alveolar Macrophages To Impact a Pro-Inflammatory
Effect. Chem Res Toxicol. 2019;32(9):1737-174.
4. Leone FT, Zhang Y, Evers-Casey S, Evins AE, Eakin M, Fathi J, Fennig K, Folan P,
Galiatsatos P, Gogineni H, Kantrow S, Kathuria H, Lamphere T, Neptune E, Pacheco MC, Pakhale S, Prezant D, Sachs DPL,
Toll B, Upson D, Xiao D, Cruz-Lopes L, Fulone I, Murray RL, O’Brien KK, Pavalagantharajah
S, Ross S, Zhang Y, Zhu M, and Farber HJ. Initiating Pharmacologic Treatment of Tobacco
Dependence in Adults: An Official ATS Clinical Practice Guideline. Am J Respir Crit
Care Med 2020;202(2):e5-e31.
5. Luo T, Li MS, Williams D, Phillippi S, Yu Q, Kantrow S, Kao YH, Celestin M, Lin WT, Tseng TS.Luo T, et al. Using social media for smoking
cessation interventions: a systematic review. Perspect Public Health. 2021 Jan;141(1):50-63.
6. Janz DR, Mackey S, Patel N, Saccoccia BP, St Romain M, Busack B, Lee H, Phan L,
Vaughn J, Feinswog D, Chan R, Auerbach L, Sausen N, Grace J, Sackey M, Das A, Gordon
AO, Schwehm J, McGoey R, Happel KI, Kantrow SP. Critically Ill Adults with COVID-19
in New Orleans and Care with an Evidence-based Protocol. Chest. 2021; 159(1):196-204.
7. Luo T, Li M, Williams D, Fritz J, Phillippi S, Yu Q, Kantrow S, Chen L, Chen Y, Beiter K, Tseng TS.Luo T, et al. Urban and Rural Disparities in
a WeChat-Based Smoking Cessation Intervention among Chinese Smokers. Int J Environ
Res Public Health. 2021 Jun 23;18(13):6731.